A pivotal lung cancer trial testing Tagrisso, AstraZeneca’s bestselling oncology therapy, has been halted due to “overwhelming” efficacy.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,